WSU OBI & TCO Corporate Innovation Showcase featuring J&J Innovation, JLabs, Blue Knight and BARDA
This event is in the past.
RSVP is closed.
Please join Wayne State University’s Office of Business Innovation & Technology Commercialization on September 7, 2022 from 12 noon to 1:00 p.m. for a virtual Corporate Innovation Showcase featuring Johnson & Johnson Innovation, JLabs, Blue Knight, and BARDA. Zoom information and our speaker bios can be found below.
Rachel Rath is the director of the BARDA Alliance and Interim Head for JLABS @ TMC for Johnson & Johnson Innovation. She is responsible for managing BLUE KNIGHT™, a joint initiative between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), which aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. Rachel leads the strategic direction, alliance management, and oversight of all operational activities related to the collaboration with BARDA, including managing the sourcing and selection of high potential companies for JLABS locations and developing global programming.
Before joining JLABS, Rachel was the chief of staff for the National Evaluation System for health Technology Coordinating Center (NESTcc)—an initiative of the Medical Device Innovation Consortium (MDIC)—that was established with funding from the U.S. Food and Drug Administration (FDA). Prior to joining NESTcc, Rachel worked at PCORI, helping to launch the Patient-Centered Clinical Research Network (PCORnet), a national effort to engage patients and leverage electronic health data to improve the speed and efficiency of clinical research in the United States.
Rachel received her MBA from Georgetown University and MPH in global health policy from The George Washington University.
Ashim Subedee is the director of the BARDA DRIVe Catalyst Office where he leads a team dedicated to fostering health security innovation ecosystem and commercialization of technologies through several public private partnerships including BARDA Ventures, BARDA Accelerator Network, and J&J – BARDA Blue Knight partnership. Prior to BARDA, Ashim was at the NIH where he supported biomedical entrepreneurship and product development by both academic and small business innovators at the NCI Small Business Development Center, NIH Small Business Education and Entrepreneurial Development (SEED) Office, and the Rapid Acceleration of Diagnostics (RADx) program. Ashim joined the federal government as a Presidential Management Fellow at the NIH and the FDA Center for Drug Evaluation and Research (CDER). He received his PhD in Biological and Biomedical Sciences with a secondary concentration on Science, Technology, and Society from Harvard University where his dissertation work was focused on molecular mechanisms of triple negative breast cancer.
Time: Sep 7, 2022 12:00 PM Eastern Time (US and Canada)
Join Zoom Meeting
Meeting ID: 893 1032 5291
One tap mobile
+13017158592,,89310325291# US (Washington DC)
Dial by your location:
+1 646 931 3860 US
+1 301 715 8592 US (Washington DC)
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 386 347 5053 US
+1 564 217 2000 US
+1 669 444 9171 US
+1 669 900 9128 US (San Jose)
+1 719 359 4580 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Find your local number: https://us02web.zoom.us/u/kwzpqDpnU